Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marrow transplantation, cost effectiveness analysis and setting limits

H G Welch1

  • 1Department of Veterans Affairs Medical Center, White River Junction, VT 05009.

Leukemia
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?

Lancet (London, England)·2001
Same author

Cost-effectiveness of screening for colorectal cancer.

Annals of internal medicine·2001
Same author

Reducing "unnecessary" antibiotic use in primary care: hard rules, soft calls.

Effective clinical practice : ECP·2001
Same author

Informed choice in cancer screening.

JAMA·2001
Same author

Women's views on breast cancer risk and screening mammography: a qualitative interview study.

Medical decision making : an international journal of the Society for Medical Decision Making·2001
Same author

Number fifteen.

Effective clinical practice : ECP·2001
Same journal

Linperlisib enhances MUC1-Tn CAR T cell efficacy by inhibiting EGR1/DUSP2 axis to prevent CAR T cell exhaustion.

Leukemia·2026
Same journal

CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia.

Leukemia·2026
Same journal

Single-cell architecture of purinergic signaling in human cord blood hematopoietic stem and progenitor cells.

Leukemia·2026
Same journal

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same journal

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026
Same journal

PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

Leukemia·2026
See all related articles

Hematopoietic stem cell transplantation is a major organ transplant procedure in the US. High costs and growth potential necessitate careful resource allocation for this life-saving therapy.

Area of Science:

  • Medicine
  • Transplantation Biology
  • Health Economics

Background:

  • Hematopoietic stem cell transplantation (HSCT) is a significant medical procedure, ranking second to kidney transplants in the US.
  • The high volume of HSCT procedures presents unique challenges compared to other organ transplants.
  • The cost of HSCT is substantial, similar to other transplantations, but it is not limited by donor organ scarcity.

Purpose of the Study:

  • To analyze the economic and resource implications of hematopoietic stem cell transplantation.
  • To highlight the need for strategic resource management in the field of transplantation.
  • To inform future healthcare policy and resource allocation decisions for HSCT.

Main Methods:

  • This study is a review of current practices and economic data in hematopoietic stem cell transplantation.

Related Experiment Videos

  • Analysis of cost factors and donor availability in comparison to other major organ transplants.
  • Assessment of growth trends and their impact on resource demands.
  • Main Results:

    • Hematopoietic stem cell transplantation is a leading transplant procedure in the United States.
    • The procedure incurs significant costs, yet benefits from a readily available donor pool.
    • Projected growth in HSCT necessitates proactive resource planning.

    Conclusions:

    • The unique economic and supply characteristics of HSCT demand specific resource management strategies.
    • Difficult resource choices are inevitable due to high costs and increasing demand for HSCT.
    • Strategic planning is crucial to ensure the sustainability and accessibility of hematopoietic stem cell transplantation.